Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.654 EUR 0.98% Market Closed
Market Cap: 105.5m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Oryzon Genomics SA

Current Assets 13.9m
Cash & Short-Term Investments 10.1m
Receivables 3.8m
Other Current Assets 7.1k
Non-Current Assets 96.8m
Long-Term Investments 25.8k
PP&E 418.6k
Intangibles 94m
Other Non-Current Assets 2.4m
Current Liabilities 14.6m
Accounts Payable 2.4m
Accrued Liabilities 452.7k
Short-Term Debt 4.8m
Other Current Liabilities 7m
Non-Current Liabilities 9.5m
Long-Term Debt 3.2m
Other Non-Current Liabilities 6.3m

Balance Sheet
Oryzon Genomics SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4
19
22
35
34
35
40
29
21
12
Cash
0
19
22
35
34
35
40
29
21
12
Cash Equivalents
4
0
0
0
0
0
0
0
0
0
Short-Term Investments
6
2
5
0
0
0
0
0
0
0
Total Receivables
1
1
1
1
1
2
2
4
4
2
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
1
1
1
1
1
2
2
4
4
2
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
10
23
28
36
36
38
42
33
25
14
PP&E Net
1
1
1
1
1
1
1
1
1
0
PP&E Gross
1
1
1
1
1
1
1
1
1
0
Accumulated Depreciation
2
2
2
2
2
2
2
2
2
2
Intangible Assets
13
15
19
22
29
40
49
60
76
90
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
1
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
2
2
2
2
2
2
2
2
2
2
Total Assets
26
N/A
41
+56%
50
+22%
61
+23%
67
+11%
80
+19%
94
+18%
95
+1%
104
+9%
107
+3%
Liabilities
Accounts Payable
1
2
2
1
2
3
2
3
5
3
Accrued Liabilities
0
1
0
0
0
0
1
1
0
1
Short-Term Debt
0
0
0
0
0
0
0
0
3
4
Current Portion of Long-Term Debt
1
1
4
6
7
6
4
3
7
6
Other Current Liabilities
2
2
1
1
1
1
1
1
3
2
Total Current Liabilities
4
5
8
9
10
11
8
9
19
16
Long-Term Debt
6
3
18
13
7
4
5
10
7
3
Deferred Income Tax
2
2
2
2
2
2
2
2
2
2
Other Liabilities
0
3
0
3
3
3
3
3
3
3
Total Liabilities
12
N/A
13
+8%
27
+106%
27
-2%
22
-16%
19
-15%
18
-4%
24
+33%
31
+29%
25
-19%
Equity
Common Stock
0
1
1
2
2
2
3
3
3
3
Retained Earnings
4
7
12
19
21
26
5
10
14
18
Additional Paid In Capital
14
30
30
48
61
80
74
74
80
92
Treasury Stock
2
2
2
2
2
1
1
1
1
1
Other Equity
5
5
5
5
5
5
5
5
5
5
Total Equity
14
N/A
28
+99%
23
-18%
34
+51%
45
+31%
61
+35%
76
+24%
71
-6%
73
+2%
82
+13%
Total Liabilities & Equity
26
N/A
41
+56%
50
+22%
61
+23%
67
+11%
80
+19%
94
+18%
95
+1%
104
+9%
107
+3%
Shares Outstanding
Common Shares Outstanding
23
27
28
33
38
45
53
53
55
61

See Also

Discover More